RNA5SP529

Across TCGA pan-cancer cohorts, RNA5SP529 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNA5SP529 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNA5SP529 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP529 expression acts as an unfavorable survival marker.

STAD and LIHC are the cancer types where RNA5SP529 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.428	0.715	.010	18	view →
LIHC	OS	Tertile	All	0.169	0.669	.032	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RNA5SP529–STAD (OS)

Open the STAD breakdown →